Dataset Viewer
Auto-converted to Parquet Duplicate
id
int64
sentence
string
label
int64
source
string
0
CoolSculpting® and CoolSculpting® Elite are FDA-cleared for the treatment of visible fat bulges in the thigh, abdomen, flank, bra fat, back fat, banana roll, and upper arm (BMI ≤30) and in submental and submandibular areas (BMI ≤46.2).
1
Claims_01.xlsx
1
It is also FDA-cleared to affect the appearance of lax tissue with submental area treatments.
1
Claims_01.xlsx
2
Stubborn fat is the #1 concern of aesthetic considerers.
1
Claims_01.xlsx
3
More than 1 in 4 US Adults are 'very' or 'extremely' bothered by stubborn fat.
1
Claims_01.xlsx
4
Nearly 3 out of 4 NIBC considerers are considering both fat-reduction and muscle-stimulation treatments.
1
Claims_01.xlsx
5
NIBC is among the top 3 aesthetic revenue contributors for practices along with neurotoxins and dermal fillers.
1
Claims_01.xlsx
6
More than 50% of CoolSculpting® patients are new to aesthetics.
1
Claims_01.xlsx
7
40% of new CoolSculpting patients return for other aesthetic treatments.
1
Claims_01.xlsx
8
CoolSculpting patients spend 3X more on aesthetic treatments.
1
Claims_01.xlsx
9
CoolSculpting patients spend 23% more on Allergan Aesthetics injectable wrinkle reducers.
1
Claims_01.xlsx
10
CoolSculpting and CoolSculpting Elite are FDA-cleared for visible fat bulges in 9 body areas.
1
Claims_01.xlsx
11
The CoolTone device is indicated for improvement of abdominal tone, strengthening of the abdominal muscles, and development for firmer abdomen.
1
Claims_01.xlsx
12
CoolTone is also indicated for strengthening, toning, and firming of buttocks and thighs.
1
Claims_01.xlsx
13
63% ownership of the NIBC market.
1
Claims_01.xlsx
14
14M+ CoolSculpting treatments delivered worldwide.
1
Claims_01.xlsx
15
20+ years of research and development.
1
Claims_01.xlsx
16
25+ patents for cryolipolysis, applicators, devices, and treatment systems.
1
Claims_01.xlsx
17
100+ peer-reviewed CoolSculpting publications.
1
Claims_01.xlsx
18
Only CoolSculpting contours the body by safely delivering permanent fat reduction in treated areas.
1
Claims_01.xlsx
19
CoolSculpting is FDA-cleared to treat 9 areas — targeting stubborn fat.
1
Claims_01.xlsx
20
CoolSculpting is a noninvasive solution with no surgery and little to no downtime.
1
Claims_01.xlsx
21
CoolSculpting delivers long-lasting results evident at 6 and 9 years after treatment, even with fluctuations in body weight.
1
Claims_01.xlsx
22
CoolSculpting is FDA-cleared for more than 13 years, and supported by over 100 peer-reviewed publications.
1
Claims_01.xlsx
23
CoolSculpting uses cryolipolysis to target and permanently reduce stubborn fat in treated areas.
1
Claims_01.xlsx
24
CoolSculpting targets and cools fat cells to temperatures that trigger fat cell apoptosis.
1
Claims_01.xlsx
25
There is no damage to surrounding tissues because lipids in fat crystallize at a warmer temperature than water in other cell types.
1
Claims_01.xlsx
26
Following treatment, fat cells enter apoptosis, and the body's immune system naturally and permanently eliminates these cells.
1
Claims_01.xlsx
27
CoolSculpting reduces stubborn (subcutaneous) fat that is resistant to diet and exercise.
1
Claims_01.xlsx
28
CoolSculpting is the only treatment FDA-cleared to treat fat in 9 different areas of the body.
1
Claims_01.xlsx
29
Powerful dual applicators deliver more treatments in the same amount of time.
1
Claims_01.xlsx
30
The Elite applicator collection allows you to personalize treatment for a wide range of body shapes and sizes.
1
Claims_01.xlsx
31
Larger, sleeker touchscreen and easy-to-navigate system interface.
1
Claims_01.xlsx
32
Detachable applicator heads for easier handling, cleaning, and storage.
1
Claims_01.xlsx
33
Universal treatment card operates any applicator for streamlined inventory management.
1
Claims_01.xlsx
34
CoolSculpting Elite applicator technology has evolved to enhance efficiency and treatment experience.
1
Claims_01.xlsx
35
Original CoolSculpting technology (2009): 60-minute treatments at -10°C treatment temperature.
1
Claims_01.xlsx
36
CoolAdvantage (2016): 35-minute treatments at -11°C treatment temperature.
1
Claims_01.xlsx
37
CoolSculpting Elite (2021): 96.6% acceptable tissue contact as reported by clinicians.
1
Claims_01.xlsx
38
Elite applicator cups deliver improved tissue contact.
1
Claims_01.xlsx
39
96.6% acceptable tissue contact with Elite applicator geometry for a more secure fit.
1
Claims_01.xlsx
40
65.7% acceptable tissue contact with CoolAdvantage applicator geometry.
1
Claims_01.xlsx
41
The redesigned C-shaped cup geometry features a wider 2.31-inch opening, branched vacuum channels, contoured design.
0
Claims_01.xlsx
42
72.9% of midsection patients noticed visible improvement 4 weeks after their first CoolSculpting Elite treatment visit.
1
Claims_01.xlsx
43
96% of surveyed CoolSculpting Elite providers reported seeing results in as few as 30 days.
1
Claims_01.xlsx
44
CoolSculpting Elite applicators come in a variety of shapes and sizes to deliver a personalized treatment.
1
Claims_01.xlsx
45
Significant fat volume reduction from baseline was seen at 4 and 8 weeks after visit 1 and at 12 weeks after visit 2.
1
Claims_01.xlsx
46
91.7% (88/96) of participants noted improvement in the fit of clothing over the treated area.
1
Claims_01.xlsx
47
89.4% (84/94) of patients would recommend CoolSculpting Elite to a friend after 2 visits.
1
Claims_01.xlsx
48
Real patient before/after outcomes: Abdomen, Flanks, Arms, Submental — shown at 8-12 weeks after 2nd visit.
1
Claims_01.xlsx
49
72% of NIBC considerers are considering both fat-reduction and muscle-stimulation treatments.
1
Claims_01.xlsx
50
Only 21% of Allergan Aesthetics NIBC users receive both CoolSculpting and CoolTone.
1
Claims_01.xlsx
51
A personal treatment plan that includes CoolTone could take your results further.
1
Claims_01.xlsx
52
CoolTone features intentionally designed pulse programming informed by muscle science and elite athletic performances.
1
Claims_01.xlsx
53
Variable pulse patterns alternate frequencies to warm up, tone, firm, and strengthen muscles while also providing active recovery.
1
Claims_01.xlsx
54
Magnetic stimulation selectively targets muscles.
1
Claims_01.xlsx
55
CoolTone is FDA cleared to tone 3 different muscle groups: abdomen, buttocks, and thighs.
1
Claims_01.xlsx
56
Skin and fat are poor conductors; muscle is a good conductor — enabling CoolTone to selectively stimulate muscle tissue.
1
Claims_01.xlsx
57
3 months after adding CoolTone treatment, patients on average doubled the amount of time they could hold a plank vs baseline.
1
Claims_01.xlsx
58
3 months after adding CoolTone treatment, patients on average increased the number of crunches they could perform by 58% vs baseline.
1
Claims_01.xlsx
59
Nearly every patient (92.9%) reported feeling stronger at 3 months after final CoolTone treatment.
1
Claims_01.xlsx
60
The majority of patients reported being happier with their overall appearance at 1 month after final CoolTone treatment.
1
Claims_01.xlsx
61
Sequential treatments of CoolTone and CoolSculpting on the abdomen delivered significant improvements in visible results and increased patient satisfaction.
1
Claims_01.xlsx
62
Only CoolSculpting Elite and CoolTone have the integrated Allē scanner linked to CoolConnect.
1
Claims_01.xlsx
63
No other aesthetic company or body contouring device provides this kind of data capture and analysis.
1
Claims_01.xlsx
64
Allergan Aesthetics offers industry-leading savings and benefits through Loyalty Programs.
1
Claims_01.xlsx
65
CoolSculpting University provides best-in-class training.
1
Claims_01.xlsx
66
The Cool Confidence Program provides patient solutions if paradoxical hyperplasia occurs.
1
Claims_01.xlsx
67
Practice Development Managers are invested in your practice.
1
Claims_01.xlsx
68
DTC National Campaign drives consumer awareness.
1
Claims_01.xlsx
69
CoolSculpting® is the treatment doctors use most for nonsurgical fat reduction.
1
Claims_01.xlsx
70
17M+ CoolSculpting® treatments performed worldwide.
1
Claims_01.xlsx
71
Treated fat cells are frozen and naturally eliminated—for good.
1
Claims_01.xlsx
72
Results may be seen as early as 1 to 3 months after treatment.
1
Claims_01.xlsx
73
With 14+ years in the market, CoolSculpting® has an established safety and efficacy profile that has been evaluated in clinical studies worldwide.
1
Claims_01.xlsx
74
CoolSculpting® is FDA-cleared to eliminate fat and treat visible bulges in 9 different areas of the body, allowing for a personalized treatment plan.
1
Claims_01.xlsx
75
Body contouring can begin where weight loss ends.
1
Claims_01.xlsx
76
Weight Loss: Fat cells shrink in volume; number of fat cells stay the same.
1
Claims_01.xlsx
77
After Noninvasive Body Contouring: Treated fat cells are permanently eliminated.
1
Claims_01.xlsx
78
An innovative, nonsurgical way to safely and effectively eliminate pinchable fat.
1
Claims_01.xlsx
79
Subcutaneous Fat: Pinchable fat found beneath the skin. Can be treated with CoolSculpting®.
1
Claims_01.xlsx
80
CoolSculpting® is not indicated for visceral fat.
1
Claims_01.xlsx
81
CoolSculpting® Elite is not a treatment for weight loss.
1
Claims_01.xlsx
82
Good candidates: individuals with stubborn diet-resistant fat, at or near ideal weight, wanting to contour specific areas.
1
Claims_01.xlsx
83
Controlled cooling gently and effectively targets fat cells underneath the skin while leaving surrounding tissue unaffected. Treated fat cells are frozen and then die.
1
Claims_01.xlsx
84
After CoolSculpting® treatment, eliminated fat cells are gone for good.
1
Claims_01.xlsx
85
CoolSculpting® is FDA-cleared to treat visible fat bulges known as stubborn fat in 9 areas of the body.
1
Claims_01.xlsx
86
Most patients need at least 2 treatment sessions, typically spaced 4-8 weeks apart.
1
Claims_01.xlsx
87
Midsection is the #1 Treated Area.
1
Claims_01.xlsx
88
Patients were happier and less self-conscious about the appearance of treated areas after completing their treatment plan.
1
Claims_01.xlsx
89
Paradoxical hyperplasia: About 1 out of 3,000 treatments (0.033%). Will not resolve on its own. Surgical intervention may be required.
1
Claims_01.xlsx
90
Rare side effects may happen in 1 to 10 out of 10,000 CoolSculpting treatments (between 0.01% to 0.1%).
1
Claims_01.xlsx
91
As an Allē Member, you can earn points on qualifying products and treatments.
1
Claims_01.xlsx
92
CoolSculpting® and CoolSculpting® Elite are FDA-cleared for visible fat bulges in 9 body areas. Not treatments for weight loss.
1
Claims_01.xlsx
93
CoolTone® helps induce muscle contractions beyond what the body can do on its own to strengthen, tone, and firm the abdomen, glutes, and thighs.
1
Claims_01.xlsx
94
The CoolTone® device is FDA-cleared for improvement of abdominal tone, strengthening of the abdominal muscles, and development for firmer abdomen.
1
Claims_01.xlsx
95
CoolTone® is also FDA-cleared for strengthening, toning, and firming of buttocks and thighs.
1
Claims_01.xlsx
96
A personal treatment plan that includes CoolTone® could take your results further.
1
Claims_01.xlsx
97
The CoolTone® device is FDA-cleared for improvement of abdominal tone, strengthening of abdominal muscles, and development for firmer abdomen. Also FDA-cleared for strengthening, toning, and firming of buttocks and thighs.
1
Claims_01.xlsx
98
92.9% of patients said they were satisfied with the treatment results 3 months after final treatment.
1
Claims_01.xlsx
99
CoolTone® is an FDA-cleared, noninvasive treatment that uses magnetic muscle stimulation to tone, firm, and strengthen muscles.
1
Claims_01.xlsx
End of preview. Expand in Data Studio

mBERT-large Claim Agent — Training Dataset v10

Sentence-level binary classification data used to fine-tune mBERT-large for claim detection in medical-aesthetics promotional material. A claim is a statement of product efficacy, safety, indication, or market performance that requires substantiation against an approved claims matrix.

Schema

column type description
id int Unique row id, 0..4717
sentence str The extracted sentence
label int 1 = claim, 0 = not a claim
source str Originating document or matrix file

Statistics

  • Rows: 4,718 — no nulls, no duplicate sentences, id unique
  • Labels: 4,165 negative (88.3%) / 553 positive (11.7%)
  • Length: median 10 words (62 chars), p95 33 words, max 238 words
  • Sources: 39 distinct, in six provenance groups
source group label 0 label 1
20docs: 3,260 14
3docs: 903 0
Claim_02.csv 1 336
Claims_01.xlsx 1 113
added 0 31
superscript_claims 0 59

Provenance

  • 20docs: / 3docs: — sentences extracted from promotional PDFs. Filenames encode the QA finding for that document (missing reference, wrong reference, not following claims matrix).
  • Claims_01.xlsx / Claim_02.csv — approved claims matrix entries, i.e. canonical positives.
  • added / superscript_claims — hand-curated positives, the latter targeting claims carrying superscript reference markers.

Known limitation: label/provenance confound

Labels are almost perfectly separable by source. Positives come overwhelmingly from the claims matrix files and curated additions; negatives come almost entirely from the extracted PDFs. Only 14 of 3,274 20docs: rows are positive, and 3docs: contains no positives at all.

A model trained on this split can reach high scores by learning matrix-entry style — terse, declarative, citation-free — rather than the semantics of what makes a statement a claim. This is a plausible contributor to recall saturation on in-the-wild promotional text, where real claims appear in running prose rather than matrix phrasing.

Mitigations worth applying before treating a v10 score as an estimate of deployed performance:

  • Hold out by source (group split), not by row, so matrix text cannot appear on both sides.
  • Report recall separately on 20docs:/3docs: positives — the only in-the-wild positives present.
  • Treat the negative set as unlabeled-leaning: PDF sentences were labeled 0 largely by absence from the matrix, so some true claims are likely mislabeled negative.

Intended use

Training and evaluating claim-detection classifiers for regulatory review workflows. It is a component of an automated pipeline, not a substitute for medical/legal/regulatory review.

Licensing and content

Derived from proprietary promotional material and claims matrices. Sentences reference commercial products and internal document identifiers. Not for redistribution or commercial use outside the originating engagement.

Downloads last month
10